Droplet reduces genomic analysis time using NVIDIA Parabricks, enabling rapid turnaround of test results
CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Droplet Biosciences, a diagnostics company pioneering lymph-based liquid biopsy testing, today announced that it is dramatically reducing genomic analysis time with NVIDIA AI infrastructure—improving test turnaround times and enabling more timely, informed patient care.
Read more at prnewswire.com
